In this review, we describe the roles of various TME components, such as immune cells, fibroblasts, blood vessels, immune checkpoint proteins, and cytokines, and their involvement in promoting resistance to TKIs in EGFR-mutant lung cancer. The gene discussed is EGFR; the disease is lung carcinoma.